Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.31B P/E 1,796.40 EPS this Y 23.90% Ern Qtrly Grth -
Income 14.23M Forward P/E 96.24 EPS next Y 37.80% 50D Avg Chg -16.00%
Sales 1.13B PEG 2.18 EPS past 5Y 15.60% 200D Avg Chg 3.00%
Dividend N/A Price/Book 9.70 EPS next 5Y 33.89% 52W High Chg -23.00%
Recommedations 2.10 Quick Ratio 3.58 Shares Outstanding 38.84M 52W Low Chg 94.00%
Insider Own 3.80% ROA 3.32% Shares Float 37.48M Beta 0.55
Inst Own 93.33% ROE 1.28% Shares Shorted/Prior 2.63M/2.76M Price 269.46
Gross Margin 62.51% Profit Margin 1.26% Avg. Volume 373,338 Target Price 204.69
Oper. Margin -1.34% Earnings Date Oct 31 Volume 1,608,294 Change -9.68%
About Penumbra, Inc.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Penumbra, Inc. News
12:45 PM 3 Reasons Growth Investors Will Love Penumbra (PEN)
11/20/24 Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
11/18/24 Inside a $400 billion bet on the brain-computer interface revolution
11/17/24 Penumbra, Inc. (PEN): A Bull Case Theory
11/07/24 There May Be Some Bright Spots In Penumbra's (NYSE:PEN) Earnings
11/06/24 Penumbra reveals positive data for algorithm-assisted thrombectomy tech
11/05/24 Here is Why Growth Investors Should Buy Penumbra (PEN) Now
11/05/24 Here's Why Penumbra (PEN) is a Strong Momentum Stock
11/05/24 New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
11/04/24 Implied Volatility Surging for Penumbra (PEN) Stock Options
11/02/24 Penumbra, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
11/01/24 Penumbra Third Quarter 2024 Earnings: Beats Expectations
10/31/24 Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market
10/31/24 Penumbra Inc (PEN) Q3 2024 Earnings Call Highlights: Strong U.S. ...
10/30/24 Penumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
10/30/24 Penumbra (PEN) Q3 Earnings and Revenues Top Estimates
10/30/24 Penumbra: Q3 Earnings Snapshot
10/30/24 Penumbra, Inc. Reports Third Quarter 2024 Financial Results
10/23/24 Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
10/15/24 Penumbra completes enrolment for THUNDER study to treat ischemic stroke
PEN Chatroom

User Image GrungyRebel Posted - 6 hours ago

$PEN

User Image StreetwiseReports Posted - 22 hours ago

Energy Co'.s Production Reaches 13 Mbbl/D; Two Wells Expected by Q1 2025: https://ow.ly/1kKj50UboOA Panoro Energy ASA recently reported increased production and upcoming exploration catalysts, according to an Auctus Advisors research note. $PEN:OSE #energystocks #oilstocks

User Image CarolSmith308 Posted - 6 days ago

$PEN It’s clear from the buzz in the market that KSCP has significant potential if it adjusts its approach.

User Image StockLight375 Posted - 1 week ago

$PEN

User Image AngelWood781 Posted - 2 weeks ago

$PEN Every time AITX pushes forward with their latest projects, it highlights just how much KSCP is lagging.

User Image IN0V8 Posted - 10/31/24

$PEN Deutsche Bank raises target price to $241 from $205 Jefferies raises target price to $250 from $215 JP Morgan raises target price to $230 from $150 Piper Sandler raises target price to $235 from $225 RBC raises target price to $232 from $222 Truist Securities raises target price to $240 from $235 Wells Fargo raises target price to $190 from $150

User Image stockpicker63 Posted - 10/31/24

Watch today ! $PEN and $OSPN

User Image AivelX Posted - 10/30/24

💡 #AivelX After-Hours Earnings Insights (4/5) 🧵 Earnings breakdown for: $MSFT, $PAYC, $PEN, $PPC MSFT - Ref.Earnings: 160 Next Day: 49% new high (max 8.6%) vs 48% new low (max -34.4%) 5 Days Later: 66% new highs, 59% new lows Same Week: 63% broke 422.9 (-2.7%) PAYC - Ref.Earnings: 123 Next Day: 66% new high (max 27%) vs 30% new low (max -42.2%) 5 Days Later: 80% new highs, 45% new lows Same Week: 54% broke 177.8 (+3.2%) PEN - Ref.Earnings: 31 Next Day: 55% new high (max 27.8%) vs 52% new low (max -13%) 5 Days Later: 68% new highs, 65% new lows Same Week: 45% broke 199 (-6.9%) PPC - Ref.Earnings: 886 Next Day: 59% new high (max 38%) vs 32% new low (max -20.2%) 5 Days Later: 72% new highs, 47% new lows Same Week: 23% broke 44.6 (-7.4%)

User Image Estimize Posted - 10/28/24

$PEN estimates distribution - here’s what 5 Estimize analysts are expecting $PEN to report for Q3 [Reporting 10/30 AMC] http://www.estimize

User Image John_Wick1234 Posted - 10/22/24

$PEN Reverse Head and Shoulder.

User Image Thestocktraderhubzee Posted - 1 month ago

$PEN Piper Sandler Reiterates Overweight on Penumbra, Raises Price Target to $225

User Image IN0V8 Posted - 1 month ago

$PEN Canaccord Genuity raises target price to $235 from $176

User Image Stocksrunner Posted - 1 month ago

🚀 Exciting market moves today! Stocks like $SJW $PEN $GWRE $MFC and $BROS are making waves with key technical indicators signaling potential future gains! stocksrunner.com/posts/1255

User Image IN0V8 Posted - 1 month ago

$PEN BTIG raises target price to $234 from $224 Truist Securities raises target price to $235 from $200

User Image themacromindset Posted - 1 month ago

Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke $PEN

User Image WeeklyTrader Posted - 1 month ago

This one’s primed for growth! $PEN None RSI: 58.58% 50-day MA: $192.34 200-day MA: $211.36

User Image insiderbuyingselling Posted - 1 month ago

$PEN new insider selling: 166 shares. http://insiderbuyingselling.com/?t=PEN

User Image insiderbuyingselling Posted - 09/24/24

$PEN new insider selling: 15000 shares. http://insiderbuyingselling.com/?t=PEN

User Image GTRmoney Posted - 2 months ago

$DKNG $PEN

User Image StockInvest_us Posted - 2 months ago

Signal alert: $PEN - PivotPoint bottom https://stockinvest.us/l/0PuxY4zwll

User Image Stock_Titan Posted - 2 months ago

$PEN Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe https://www.stocktitan.net/news/PEN/penumbra-receives-ce-mark-for-computer-assisted-vacuum-thrombectomy-au37daxu8r99.html

User Image MakingMoney20 Posted - 2 months ago

$PEN Try some of this instead! DIVY Alert! $MO $1.02 / share/ Qtr. That's 7.75 % ! (wow) Time is running out. Last chance for this Quarter is today. Ex date Monday9/16. Hard to beat.

User Image 123rs123 Posted - 2 months ago

$PEN this will easily be 280+ by end of the year. expect a massive beat and guidance raise on Q3 print, management taking their bread and butter strategy of sandbagging the quarter before to reset expectations. it was so obvious, that the stock immediately gained back all of it's AH losses on Q2's print management also initiating a massive buyback while the shares were massively undervalued. they know how to treat shareholders right!

User Image Looking4Bargain Posted - 2 months ago

$PEN looking for this to hit $270 ish or buyout by someone major. This is another good growth company. Been in this since they decided to start expanding operations and have great expectations from them.

User Image Looking4Bargain Posted - 2 months ago

$NARI long term here and a lookback at the past. I remember $PEN shared similar history 3 years ago and we were looking from Shockwave just near missing such fate - lessons learnt. Thanks to Doug and operations team navigating carefully around production and keeping product quality and design in close checks. Great team making great product. I believe this will still recover but just needs some time.

User Image Thestocktraderhubzee Posted - 2 months ago

$PEN Leerink Partners Initiates Coverage On Penumbra with Outperform Rating, Announces Price Target of $263

User Image Thestocktraderhubzee Posted - 08/28/24

$PEN BTIG Maintains Buy on Penumbra, Raises Price Target to $224

User Image Quantumup Posted - 08/28/24

Deutsche Bank reit'd $NARI Buy/$68~recall=correction not withdrawal—safety concerns appear2b technique vs design—based on🏁MD survey doesn't see sig risk2rev est—in worst case where ClotTriever XL volumes go2 zero, DB believes this would impact <5% of total CT volumes: $pen $spy

User Image gerrard87 Posted - 08/24/24

$NARI $PEN competitor is running haha

User Image StockInvest_us Posted - 08/23/24

Signal alert: $PEN - PivotPoint bottom https://stockinvest.us/l/5GiUfqgWPG

Analyst Ratings
Stifel Buy Sep 17, 24
Leerink Partners Outperform Sep 3, 24
BTIG Buy Aug 28, 24
Citigroup Neutral Aug 22, 24
BTIG Buy Jul 31, 24
Baird Outperform Jul 31, 24
RBC Capital Outperform Jul 31, 24
Truist Securities Buy Jul 31, 24
Canaccord Genuity Buy Jul 31, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sarna Surbhi Director Director Jan 02 Sell 247.68 85 21,053 2,295 01/04/24
Grewal Harpreet Director Director Jan 03 Sell 240.82 170 40,939 8,980 01/04/24
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Dec 27 Option 22.04 2,450 53,998 63,597 12/29/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Dec 01 Sell 225.41 600 135,246 62,251 12/05/23
O'Rourke Bridget Director Director Nov 30 Sell 226.41 150 33,962 4,214 12/04/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Nov 14 Sell 213.82 600 128,292 63,037 11/16/23
Elsesser Adam CEO and President CEO and President Oct 11 Sell 220.96 9,670 2,136,683 10/13/23
Elsesser Adam CEO and President CEO and President Oct 11 Option 7.75 9,670 74,942 9,670 10/13/23
Shiu Lambert Chief Accounting Off.. Chief Accounting Officer Oct 09 Option 12.36 2,750 33,990 19,466 10/11/23
Grewal Harpreet Director Director Oct 02 Sell 240.99 170 40,968 9,150 10/04/23
Sarna Surbhi Director Director Oct 02 Sell 240.99 85 20,484 2,380 10/04/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Oct 02 Sell 238.59 600 143,154 63,637 10/04/23
Elsesser Adam CEO and President CEO and President Sep 11 Sell 298.4 9,666 2,884,334 09/13/23
Elsesser Adam CEO and President CEO and President Sep 11 Option 7.75 9,666 74,912 9,666 09/13/23
Kassing Don W. Director Director Sep 08 Sell 288.66 444 128,165 1,458 09/12/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Sep 01 Sell 265.38 600 159,228 64,237 09/06/23
Grewal Harpreet Director Director Sep 01 Sell 266.62 340 90,651 9,320 09/06/23
Sarna Surbhi Director Director Sep 01 Sell 266.62 85 22,663 2,465 09/06/23
O'Rourke Bridget Director Director Sep 01 Sell 266.62 100 26,662 4,364 09/06/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Aug 14 Sell 249.14 600 149,484 64,837 08/16/23
Elsesser Adam CEO and President CEO and President Aug 11 Sell 247.41 9,666 2,391,465 08/14/23
Elsesser Adam CEO and President CEO and President Aug 11 Option 7.75 9,666 74,912 9,666 08/14/23
Wilder Thomas Director Director Aug 07 Sell 253.48 340 86,183 340 08/09/23
Kassing Don W. Director Director Aug 08 Sell 251 323 81,073 1,902 08/09/23
Elsesser Adam CEO and President CEO and President Jul 11 Option 7.75 9,666 74,912 9,666 07/13/23
Elsesser Adam CEO and President CEO and President Jul 11 Sell 324.24 9,666 3,134,104 07/13/23
Sarna Surbhi Director Director Jul 03 Sell 341.45 27 9,219 2,550 07/06/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Jul 03 Sell 340.63 900 306,567 65,437 07/06/23
Elsesser Adam CEO and President CEO and President Jun 12 Sell 324.26 9,666 3,134,297 06/14/23
Elsesser Adam CEO and President CEO and President Jun 12 Option 7.75 9,666 74,912 9,666 06/14/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Jun 01 Sell 310.2 900 279,180 66,337 06/05/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary May 12 Sell 320.61 1,500 480,915 68,925 05/16/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary May 12 Option 22.04 652 14,370 70,425 05/16/23
Elsesser Adam CEO and President CEO and President May 11 Sell 319.05 9,666 3,083,937 05/15/23
Elsesser Adam CEO and President CEO and President May 11 Option 7.75 9,666 74,912 9,666 05/15/23
Bose Arani Director Director May 01 Sell 286.22 5,000 1,431,100 182,629 05/03/23
Bose Arani Director Director Apr 03 Sell 275.93 5,000 1,379,650 431,342 04/05/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Apr 03 Sell 277.69 600 166,614 69,960 04/05/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Apr 03 Option 22.04 600 13,224 70,560 04/05/23
Sarna Surbhi Director Director Apr 03 Sell 276.37 28 7,738 2,577 04/05/23
Grewal Harpreet Director Director Mar 29 Sell 271 875 237,125 9,660 03/31/23
Grewal Harpreet Director Director Mar 15 Sell 254.98 875 223,108 10,535 03/17/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Mar 01 Sell 258.21 600 154,926 69,960 03/03/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Mar 01 Option 22.04 600 13,224 70,560 03/03/23
Grewal Harpreet Director Director Mar 01 Sell 259.48 710 184,231 11,410 03/03/23
Bose Arani Director Director Mar 01 Sell 258.38 5,000 1,291,900 436,342 03/03/23
Bose Arani Director Director Feb 01 Sell 253.89 5,000 1,269,450 440,662 02/03/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Dec 28 Option 22.04 5,750 126,730 69,960 02/03/23
Kassing Don W. Director Director Jan 27 Sell 243.54 693 168,773 1,545 01/31/23
Bose Arani Director Director Jan 23 Sell 250.25 20,000 5,005,000 445,662 01/25/23